Drug intelligence / Profile preview

Fufang Yinchai Granules

Development stage: Unknown
Lead developer: Tianchang Yifan Pharmaceutical
Administration: Oral

Overview

Fufang Yinchai Granules is a Traditional Chinese Medicine (TCM) compound formulation primarily used for treating wind-heat common cold and influenza. Its therapeutic actions include clearing heat, relieving exterior symptoms, and stopping cough. It is indicated for symptoms such as fever, cough, nasal congestion with runny nose, and sore throat. The drug exhibits antiviral, antibacterial, anti-inflammatory, and immune-modulating properties.

Other names: 复方银柴颗粒Yinchai Granules银柴颗粒

Beyond the preview

Go deeper on Fufang Yinchai Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fufang Yinchai Granules.

Explore the full profile